Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells

被引:43
作者
Kim, M.
Madlambayan, G. J. [2 ]
Rahman, M. M.
Smallwood, S. E.
Meacham, A. M. [2 ]
Hosaka, K. [1 ]
Scott, E. W. [1 ]
Cogle, C. R. [2 ]
McFadden, G.
机构
[1] Univ Florida, Coll Med, Dept Mol Genet & Microbiol,McKnight Brain Inst, Program Stem Cell Biol & Regenerat Med, Gainesville, FL USA
[2] Univ Florida, Coll Med, Dept Med, Div Hematol Oncol, Gainesville, FL USA
关键词
CANCER; HOST;
D O I
10.1038/leu.2009.219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2313 / 2317
页数:6
相关论文
共 7 条
[1]   Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer [J].
Kirn, David H. ;
Thorne, Steve H. .
NATURE REVIEWS CANCER, 2009, 9 (01) :64-71
[2]   Poxvirus tropism [J].
McFadden, G .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :201-213
[3]   Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer [J].
Stanford, Marianne M. ;
McFadden, Grant .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (09) :1415-1425
[4]   Myxoma virus in the European rabbit: interactions between the virus and its susceptible host [J].
Stanford, Marianne M. ;
Werden, Steven J. ;
Mc Fadden, Grant .
VETERINARY RESEARCH, 2007, 38 (02) :299-318
[5]   RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages [J].
Wang, Fuan ;
Gao, Xiujuan ;
Barrett, John W. ;
Shao, Qing ;
Bartee, Eric ;
Mohamed, Mohamed R. ;
Rahman, Masmudur ;
Werden, Steve ;
Irvine, Timothy ;
Cao, Jingxin ;
Dekaban, Gregory A. ;
McFadden, Grant .
PLOS PATHOGENS, 2008, 4 (07)
[6]   Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor [J].
Wang, G ;
Barrett, JW ;
Stanford, M ;
Werden, SJ ;
Johnston, JB ;
Gao, XJ ;
Sun, M ;
Cheng, JQ ;
McFadden, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (12) :4640-4645
[7]   A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts [J].
Yang, H ;
Eaves, C ;
de Lima, M ;
Lee, MS ;
Champlin, RE ;
McMannis, JD ;
Robinson, SN ;
Niu, T ;
Decker, WK ;
Xing, D ;
Ng, J ;
Li, S ;
Yao, X ;
Eaves, AC ;
Jones, R ;
Andersson, BS ;
Shpall, EJ .
BONE MARROW TRANSPLANTATION, 2006, 37 (06) :575-582